Activated ERK expression in relation with B-RAF gene mutations in urothelial bladder carcinoma

被引：0
|
作者：
Karlou, Maria [1 ]
Boltetsou, Evmorfia [1 ]
Saetta, Angelica A. [1 ]
Papanastasiou, Pollyanthi [1 ]
Levidou, Georgia [1 ]
Stamatelli, Anigeliki [1 ]
Thymara, Irene [1 ]
Pavlopoulos, Petros [1 ]
Korkolopoulou, Penelope [1 ]
Patsouris, Efstratios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Pathol 1, Athens, Greece
来源：
VIRCHOWS ARCHIV | 2007年 / 451卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：566 / 567
页数：2
相关论文
共 50 条
  • [1] Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations
    Karlou, Maria
    Saetta, Angelica A.
    Korkolopoulou, Penelope
    Levidou, Georgia
    Papanastasiou, Pollyanthi
    Boltetsou, Evmorfia
    Isaiadis, Dimitrios
    Pavlopoulos, Petros
    Thymara, Irene
    Thomas-Tsagli, Euphemia
    Patsouris, Efstratios
    PATHOLOGY, 2009, 41 (04) : 327 - 334
  • [2] ERK and pERK expression, B-RAF mutations and microsatellite instability in colorectal cancer
    Saetta, Angelika. A.
    Gigelou, Fanie
    Korkolopoulou, Penelope
    Kavantzas, Nikolaos
    Levidou, Georgia
    Papanastasiou, Polyanthi
    Starnatelli, Angeliki
    Karlou, Maria
    Michalopoulos, Nikolaos V.
    Patsouris, Efstratios
    VIRCHOWS ARCHIV, 2007, 451 (02) : 564 - 565
  • [3] ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics
    Georgia Levidou
    Angelica A Saetta
    Fanie Gigelou
    Maria Karlou
    Polyanthi Papanastasiou
    Angeliki Stamatelli
    Nikolaos Kavantzas
    Nikolaos V Michalopoulos
    George Agrogiannis
    Efstratios Patsouris
    Penelope Korkolopoulou
    World Journal of Surgical Oncology, 10
  • [4] ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics
    Levidou, Georgia
    Saetta, Angelica A.
    Gigelou, Fanie
    Karlou, Maria
    Papanastasiou, Polyanthi
    Stamatelli, Angeliki
    Kavantzas, Nikolaos
    Michalopoulos, Nikolaos V.
    Agrogiannis, George
    Patsouris, Efstratios
    Korkolopoulou, Penelope
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [5] Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
    Wan, PTC
    Garnett, MJ
    Roe, SM
    Lee, S
    Niculescu-Duvaz, D
    Good, VM
    Jones, CM
    Marshall, CJ
    Springer, CJ
    Barford, D
    Marais, R
    CELL, 2004, 116 (06) : 855 - 867
  • [6] No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract
    Stoehr, R
    Brinkmann, A
    Filbeck, T
    Gamper, C
    Wild, P
    Blaszyk, H
    Hofstaedter, F
    Knuechel, R
    Hartmann, A
    ONCOLOGY REPORTS, 2004, 11 (01) : 137 - 141
  • [7] Lack of B-RAF Mutations in Head and Neck Squamous Cell Carcinoma
    Ali, M. Al Sheikh
    Gunduz, M.
    Gunduz, E.
    Tamamura, R.
    Beder, L.
    Tominaga, S.
    Onoda, T.
    Yamanaka, N.
    Grenman, R.
    Shimizu, K.
    Nagai, N.
    Nagatsuka, H.
    FOLIA BIOLOGICA, 2008, 54 (05) : 157 - 161
  • [8] Analysis of PIK3CA and B-RAF gene mutations in human astrocytomas: association with activation of ERK and AKT
    El-Habr, E. A.
    Tsiorva, P.
    Theodorou, M.
    Levidou, G.
    Korkolopoulou, P.
    Vretakos, G.
    Petraki, L.
    Michalopoulos, N. V.
    Patsouris, E.
    Saetta, A. A.
    CLINICAL NEUROPATHOLOGY, 2010, 29 (04) : 239 - 245
  • [9] HAIRY CELL LEUKEMIA AND B-RAF MUTATIONS
    Olgun, A.
    Baskin, Y.
    Medeni, S. Solmaz
    Alacacioglu, I.
    Akbapour, M.
    Uysal, T.
    Birge, O.
    Ozkal, S.
    Ellidokuz, H.
    Ozcan, M. A.
    HAEMATOLOGICA, 2017, 102 : 754 - 754
  • [10] B-Raf mutations - old and new drugs
    Flaherty, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 46 - 47
12345